(Q26784047)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26342008%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

title

Neoepitopes of Cancers: Looking Back, Looking Ahead (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26342008%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

author name string

Pramod K Srivastava

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26342008%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

language of work or name

English

0 references

publication date

1 September 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26342008%20AND%20SRC:MED&resulttype=core&format=json

Cancer Immunology Research

23 February 2020

published in

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26342008%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26342008%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26342008%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

page(s)

969-977

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26342008%20AND%20SRC:MED&resulttype=core&format=json

Cloning genes encoding MHC class II-restricted antigens: mutated CDC27 as a tumor antigen

23 February 2020

cites work

1 reference

12 December 2020

CD91: a receptor for heat shock protein gp96

1 reference

12 December 2020

The immunoprotective MHC II epitope of a chemically induced tumor harbors a unique mutation in a ribosomal protein

1 reference

12 December 2020

Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses

1 reference

12 December 2020

Vaccination of Metastatic Melanoma Patients With Autologous Tumor-Derived Heat Shock Protein gp96-Peptide Complexes: Clinical and Immunologic Findings

1 reference

12 December 2020

Analysis of the B-cell repertoire against antigens expressed by human neoplasms

1 reference

12 December 2020

Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary autochthonous host

1 reference

12 December 2020

The response of autologous T cells to a human melanoma is dominated by mutated neoantigens

1 reference

12 December 2020

GM-CSF gene-modifed cancer cell immunotherapies: of mice and men.

1 reference

12 December 2020

A quantitative analysis of the variables affecting the repertoire of T cell specificities recognized after vaccinia virus infection

1 reference

12 December 2020

Epitope landscape in breast and colorectal cancer.

1 reference

12 December 2020

Phase III comparison of vitespen, an autologous tumor-derived heat shock protein gp96 peptide complex vaccine, with physician's choice of treatment for stage IV melanoma: the C-100-21 Study Group.

1 reference

12 December 2020

Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1

1 reference

12 December 2020

Modeling the repertoire of true tumor-specific MHC I epitopes in a human tumor

1 reference

12 December 2020

Correlation of clinical and immunological data in a metastatic melanoma patient with heterogeneous tumor responses to ipilimumab therapy

1 reference

12 December 2020

Anti-CTLA-4 antibody therapy: immune monitoring during clinical development of a novel immunotherapy

1 reference

12 December 2020

Exploiting the mutanome for tumor vaccination.

1 reference

12 December 2020

Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting

1 reference

12 December 2020

Inefficient exogenous loading of a tapasin-dependent peptide onto HLA-B*44:02 can be improved by acid treatment or fixation of target cells

1 reference

12 December 2020

Pathways of antigen processing

1 reference

12 December 2020

Low concordance of multiple variant-calling pipelines: practical implications for exome and genome sequencing.

1 reference

12 December 2020

Cancer genome landscapes

1 reference

12 December 2020

Comparing somatic mutation-callers: beyond Venn diagrams

1 reference

12 December 2020

Tumor exome analysis reveals neoantigen-specific T-cell reactivity in an ipilimumab-responsive melanoma

1 reference

12 December 2020

Combining next-generation sequencing and immune assays: a novel method for identification of antigen-specific T cells

1 reference

12 December 2020

Heat-shock protein peptide complex-96 vaccination for recurrent glioblastoma: a phase II, single-arm trial

1 reference

12 December 2020

Global optimization of somatic variant identification in cancer genomes with a global community challenge

1 reference

12 December 2020

Neo-antigens predicted by tumor genome meta-analysis correlate with increased patient survival

1 reference

12 December 2020

Systematic identification of personal tumor-specific neoantigens in chronic lymphocytic leukemia

1 reference

12 December 2020

HLA-binding properties of tumor neoepitopes in humans

1 reference

12 December 2020

Clonal evolution in breast cancer revealed by single nucleus genome sequencing.

1 reference

12 December 2020

Genomic and bioinformatic profiling of mutational neoepitopes reveals new rules to predict anticancer immunogenicity

1 reference

12 December 2020

Genetic basis for clinical response to CTLA-4 blockade in melanoma

1 reference

12 December 2020

Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing.

1 reference

12 December 2020

Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens

1 reference

12 December 2020

Immunoprevention of chemical carcinogenesis through early recognition of oncogene mutations

1 reference

12 December 2020

Nivolumab and ipilimumab versus ipilimumab in untreated melanoma

1 reference

12 December 2020

Mutant MHC class II epitopes drive therapeutic immune responses to cancer

1 reference

12 December 2020

Individually distinct transplantation antigens of chemically induced mouse tumors

1 reference

12 December 2020

Search for common antigenicities among twenty-five sarcomas induced by methylcholanthrene.

1 reference

12 December 2020

Acquisition of transforming properties by alternative point mutations within c-bas/has human proto-oncogene

1 reference

12 December 2020

Cancer immunology: the search for specificity--G. H. A. Clowes Memorial lecture

1 reference

12 December 2020

The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes

1 reference

12 December 2020

A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides

1 reference

12 December 2020

Multiple lineages of tumors express a common tumor antigen, P1A, but they are not cross-protected

1 reference

12 December 2020

A unique tumor antigen produced by a single amino acid substitution

1 reference

12 December 2020

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

1 reference

12 December 2020

Peptide-binding heat shock proteins in the endoplasmic reticulum: role in immune response to cancer and in antigen presentation.

1 reference

12 December 2020

Differences and similarities in the A2.1-restricted cytotoxic T cell repertoire in humans and human leukocyte antigen-transgenic mice

1 reference

12 December 2020

Human tumor antigens recognized by T lymphocytes

1 reference

12 December 2020

10.1158/2326-6066.CIR-15-0134

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26342008%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26342008%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference